Author

Michael R Bishop

Observed names: M. R. Bishop, Michael R. Bishop

Institution: University of Chicago

Observed institution: University of Chicago

OpenAlex ID: A5148681632

P356: Subgroup Analyses of Kte-x19, an Anti-cd19 Chimeric Antigen Receptor (car) T-cell Therapy, in Adult Patients With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia (r/r B-all) in Zuma-3

2022 · B. D. Shah, R. D. Cassaday, et al. · HemaSphere · 4

Activity of Autologous Anti-CD19 Chimeric Antigen Receptor T-cell Therapy in CD19-Negative Large B-cell Lymphoma: A Cell Therapy Consortium Real World Experience

2026 · Chen Zhang, Xiaowen Sun, et al. · Transplantation and Cellular Therapy · 1

TP53/PLCG2-mutated diffuse large B-cell lymphoma richter transformation (DLBCL-RT) of CLL with unusual CD2 and PD-1 expression

2022 · Emily Symes, Peng Wang, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1

CD19 CAR T-cell therapy (GLPG5101) for relapsed or refractory B-cell non-Hodgkin lymphoma (ATALANTA-1): phase 1 results from a single-arm, multicentre, phase 1/2 study

2026 · Marie José Kersten, Maria T Kuipers, et al. · The Lancet Haematology

POSTER: ALL-1125: Improving Efficacy and Safety Outcomes in Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in Morphologic Remission Treated With Obecabtagene Autoleucel

2026 · Claire Roddie, Jae H Park, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: ALL-706: Clinical Outcomes in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia Who Achieved Remission Following Treatment With Obecabtagene Autoleucel in the FELIX Study

2026 · Elias Jabbour, Jae H Park, et al. · Clinical Lymphoma Myeloma & Leukemia

ALL-706: Clinical Outcomes in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia Who Achieved Remission Following Treatment With Obecabtagene Autoleucel in the FELIX Study

2026 · Elias Jabbour, Jae H Park, et al. · Clinical Lymphoma Myeloma & Leukemia

ALL-777: The Effect of Obecabtagene Autoleucel on Adult Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia and Extramedullary Disease

2026 · Jae H Park, Karamjeet S Sandhu, et al. · Clinical Lymphoma Myeloma & Leukemia

ALL-1125: Improving Efficacy and Safety Outcomes in Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in Morphologic Remission Treated With Obecabtagene Autoleucel

2026 · Claire Roddie, Jae H Park, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: ALL-777: The Effect of Obecabtagene Autoleucel on Adult Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia and Extramedullary Disease

2026 · Jae H Park, Karamjeet S Sandhu, et al. · Clinical Lymphoma Myeloma & Leukemia

Abstract 3702: No impact of dexamethasone on CAR-T cell expansion in vitro and in patients with RRMM

2026 · Lelisa Gemta, Lawrence P. Andrews, et al. · Cancer Research

Chimeric Antigen Receptor (CAR) T-cell Persistence at Month 3 (M3) Predicts Clinical Outcomes in Adult Patients (pts) with Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia (R/R B-ALL) Treated with Obecabtagene autoleucel (obe-cel)

2026 · Claire Roddie, Jae H Park, et al. · Transplantation and Cellular Therapy

Impact of CD19 CAR Product on Resource Utilization through Day 28 for Large Cell Lymphoma

2026 · Gunjan L. Shah, Maria Bromberg, et al. · Transplantation and Cellular Therapy

CT-945: Low Rates of High-Grade Toxicities With GLPG5101, a Fresh, Stem-Like, Early Memory Phenotype Anti-CD19 CAR T-Cell Therapy, in Patients With Non-Hodgkin Lymphoma in the ATALANTA-1 Study

2025 · Joost S.P. Vermaat, Sébastien Anguille, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: CT-945 Low Rates of High-Grade Toxicities With GLPG5101, a Fresh, Stem-Like, Early Memory Phenotype Anti-CD19 CAR T-Cell Therapy, in Patients With Non-Hodgkin Lymphoma in the ATALANTA-1 Study

2025 · Joost S.P. Vermaat, Sébastien Anguille, et al. · Clinical Lymphoma Myeloma & Leukemia

Erratum to: “Tumor burden-guided dosing contributes to mitigation of immunotoxicities following treatment with obecabtagene autoleucel in adult patients with relapsed/ refractory B-cell acute lymphoblastic leukemia”

2020 · Elias Jabbour, Karamjeet S. Sandhu, et al. · Haematologica

Works count: 16

Citation count: 6

H-index: 1

I10-index: